More on 4151

- Summary
- Chart
- Profile
- Historical

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Friends, Peers and Foes (?): KNBWY, KYKOY, ARDX, ORTX BBIO (more...)

Feb 27, 2026 02:14 AM Cowellnex and Metagen Launch Joint Research Utilizing Independently Acquired High‑Precision Gut Microbiota Data
Dec 11, 2025 02:30 AM Kyowa Kirin names Abdul Mullick as CEO effective March 2026
Dec 11, 2025 02:30 AM Kyowa Kirin Announces Proposed Appointment of Abdul Mullick to President and Chief Executive Officer, While Former CEO Masashi Miyamoto to Remain Chairman
Dec 8, 2025 10:30 AM Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI™ (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML
Nov 13, 2025 10:51 AM FDA approves KOMZIFTI for relapsed NPM1-mutated acute myeloid leukemia
Nov 13, 2025 10:51 AM Kura Oncology and Kyowa Kirin Announce FDA Approval of KOMZIFTI™ (ziftomenib), the First and Only Once-Daily Targeted Therapy for Adults with Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukem
Nov 3, 2025 09:14 AM Kura Oncology and Kyowa Kirin Announce Presentations of Ziftomenib Ven/Aza Combination Data in Frontline and Relapsed/Refractory NPM1-m or KMT2A-r Acute Myeloid Leukemia at 2025 ASH Annual Meeting
Nov 3, 2025 03:28 AM Kyowa Kirin names Julie Dehaene-Puype as international president
Nov 3, 2025 03:28 AM Kyowa Kirin International Announces Appointment of Julie Dehaene-Puype as President for the Region
Oct 22, 2025 03:30 AM Global Registry Data Show Meaningful Overall Survival Benefit in Patients with Advanced Cutaneous T-cell Lymphoma (CTCL) treated with POTELIGEO (mogamulizumab)
View All Articles

Entities mentioned with 4151

View All Entities